Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy-Reference-Cited by-同舟云学术

Virtual screening reveals aprepitant to be a potent inhibitor of neutral sphingomyelinase 2: implications in blockade of exosome release in cancer therapy

Published:2023-03-08 Issue:10 Volume:149 Page:7207-7216
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Moloudizargari Milad,Hekmatirad Shirin,Gharaghani Sajjad,Moghadamnia Ali Akbar,Najafzadehvarzi Hossein,Asghari Mohammad Hossein^ORCID

Funder

Babol University of Medical Sciences

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04674-6.pdf

Reference42 articles.

1. Abad E, Lyakhovich A (2022) Movement of mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance. Chem Med Chem 17(4):e202100642

2. Baghban R, Roshangar L, Jahanban-Esfahlan R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T, Zare P (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal. https://doi.org/10.1186/s12964-020-0530-4

3. Berger M, Neth O, Ilmer M, Garnier A, Salinas-Martín MV, de Agustín Asencio JC, von Schweinitz D, Kappler R, Muñoz M (2014) Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol 60(5):985–994

4. Bilousova T, Simmons BJ, Knapp RR, Elias CJ, Campagna J, Melnik M, Chandra S, Focht S, Zhu C, Vadivel K (2020) Dual neutral sphingomyelinase-2/acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease. ACS Chem Biol 15(6):1671–1684

5. Butt SS, Badshah Y, Shabbir M, Rafiq M (2020) Molecular docking using chimera and autodock vina software for nonbioinformaticians. JMIR Bioinform Biotechnol 1(1):e14232

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024